Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Furin-like cysteine rich region family protein | 0.0919 | 0.1503 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0494 | 0.0526 | 0.3501 |
Echinococcus multilocularis | insulin receptor | 0.0295 | 0.0067 | 0.0443 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.4616 | 1 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.4616 | 1 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0488 | 0.0512 | 0.3405 |
Entamoeba histolytica | fatty acid elongase, putative | 0.06 | 0.0768 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0919 | 0.1503 | 1 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0295 | 0.0067 | 0.0443 |
Echinococcus granulosus | insulin receptor | 0.0295 | 0.0067 | 0.0443 |
Schistosoma mansoni | tyrosine kinase | 0.0488 | 0.0512 | 0.3405 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0494 | 0.0526 | 0.3501 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.4616 | 1 | 0.5 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0919 | 0.1503 | 1 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0919 | 0.1503 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0295 | 0.0067 | 0.0443 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0919 | 0.1503 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0295 | 0.0067 | 0.0398 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0494 | 0.0526 | 0.3501 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0295 | 0.0067 | 0.0398 |
Entamoeba histolytica | fatty acid elongase, putative | 0.06 | 0.0768 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0488 | 0.0512 | 0.3405 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0295 | 0.0067 | 0.0443 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.4616 | 1 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.4616 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.06 | 0.0768 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0295 | 0.0067 | 0.0443 |
Entamoeba histolytica | fatty acid elongase, putative | 0.06 | 0.0768 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.4616 | 1 | 0.5 |
Echinococcus multilocularis | 0.0284 | 0.0043 | 0.0286 | |
Entamoeba histolytica | fatty acid elongase, putative | 0.06 | 0.0768 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0494 | 0.0526 | 0.3501 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.4616 | 1 | 0.5 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0494 | 0.0526 | 0.3501 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.